Fig. 5From: TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancerFunctional enrichment and tumor mutation analysis between high- and low- risk groups. A GESA analysis in the high- risk group. B GESA analysis in the low- risk group. D The bar plot of GO enrichment analysis. E The bubble plot for KEGG enrichment analysis. C, F Differences in mutation frequency between high- and low- risk groups. G Tumor mutation burden between high- and low-risk groups. H Survival analysis between subgroupsBack to article page